Health Care & Life Sciences » Biotechnology | Immune Therapeutics Inc.

Immune Therapeutics Inc.

Immune Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$2.67 M
Shares Outstanding
445.58 M
Public Float
385.48 M

Profile

Address
37 North Orange Avenue
Orlando Florida 32801
United States
Employees -
Website http://www.immunetherapeutics.com
Updated 07/08/2019
Immune Therapeutics, Inc. is a biopharmaceutical company focuses on the commercialization of affordable non-toxic immunotherapies focused on the activation and rebalancing of the body's immune system. It specializes in the treatment of cancers, HIV, autoimmune diseases, inflammatory conditions, and other opportunistic infections for chronic often life-threatening diseases through the mobilization of the body's immune system in emerging nations using existing clinical data. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Financials

View All
Created with Highcharts 5.0.14Immune Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.106 060106 06048 25348 25316 31316 31319 52119 5217 3167 3168 1758 175201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Immune Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000161633001131132013201420152016201720180255075100125

Roscoe M. Moore
Chairman
Roscoe M. Moore
Chairman